Panniculitis
170 Panniculitis Carrie Ann R. Cusack and Matthew Fanelli Evidence Levels: A Double-blind study B Clinical trial ≥ 20 subjects C Clinical trial < 20 subjects D Series ≥ 5 subjects E Anecdotal case reports…
Dermatology
Pyoderma gangrenosum
205 Pyoderma gangrenosum John Berth-Jones Evidence Levels: A Double-blind study B Clinical trial ≥ 20 subjects C Clinical trial < 20 subjects D Series ≥ 5 subjects E Anecdotal case reports Pyoderma gangrenosum (PG) is…
Mycosis fungoides
155 Mycosis fungoides Pierluigi Porcu and Henry K. Wong Evidence Levels: A Double-blind study B Clinical trial ≥ 20 subjects C Clinical trial < 20 subjects D Series ≥ 5 subjects E Anecdotal case reports…
Langerhans cell histiocytosis
119 Langerhans cell histiocytosis Thiviyani Maruthappu and Anthony C. Chu Evidence Levels: A Double-blind study B Clinical trial ≥ 20 subjects C Clinical trial < 20 subjects D Series ≥ 5 subjects E Anecdotal case…
Pregnancy dermatoses
194 Pregnancy dermatoses Wolfgang Jurecka Evidence Levels: A Double-blind study B Clinical trial ≥ 20 subjects C Clinical trial < 20 subjects D Series ≥ 5 subjects E Anecdotal case reports Skin changes during pregnancy…
Rocky Mountain spotted fever and other rickettsial infections
212 Rocky Mountain spotted fever and other rickettsial infections Sean C. McElligott, George G. Kihiczak and Robert A. Schwartz Evidence Levels: A Double-blind study B Clinical trial ≥ 20 subjects C Clinical trial…
Prurigo nodularis
196 Prurigo nodularis Christopher Rowland Payne Evidence Levels: A Double-blind study B Clinical trial ≥ 20 subjects C Clinical trial < 20 subjects D Series ≥ 5 subjects E Anecdotal case reports Prurigo nodularis (PN)…
Pediculosis
176 Pediculosis Jaime R. Gropper and Jacob O. Levitt Evidence Levels: A Double-blind study B Clinical trial ≥ 20 subjects C Clinical trial < 20 subjects D Series ≥ 5 subjects E Anecdotal case reports…
Sarcoidosis
214 Sarcoidosis Preston W. Chadwick and Warren R. Heymann Evidence Levels: A Double-blind study B Clinical trial ≥ 20 subjects C Clinical trial < 20 subjects D Series ≥ 5 subjects E Anecdotal case reports…
